Module 1

In this module, we describe PrEP and the evidence from the formative international studies that led to guidelines in the US and abroad recommending its implementation for HIV prevention For patients, we discuss the importance of assessing your individual need and readiness to begin PrEP. For providers, we present case studies of implementation projects around the world
Please be sure to follow the link on the right below each video to complete a short speaker evaluation Thanks!

Module 2

In this module, we distinguish PrEP from post-exposure prophylaxis (PEP) and when each is most appropriate We also review what’s in the pipeline for other forms of PrEP medication and modes of delivery For Providers, we explain the activity of tenofovir/emtricitibine against HIV infection, its general pharmacodynamics and the application of clinical practice guidelines in a community clinic

Module 3

In this module, we review issues related to accessing and navigating the healthcare system that are relevant to priority populations for PrEP, including men who have sex with men (MSM), women, sero-different couples, adolescents, transgender persons, sex workers and persons who inject drugs or experience coercive sex For patients, content covers self-advocacy and population-focused concerns and resources for PrEP services For providers, we discuss the need and approach for tailoring PrEP for priority and often under-served communities with cultural humility

Module 4

In this module, we review issues related to accessing PrEP For providers, we consider how to identify priority populations for PrEP in your service area, discuss the relative costs and outcomes for PrEP as a public health program, key elements of a PrEP business plan and the role of community outreach. For patients, barriers to accessing services are addressed

Module 5

In this module, steps of the first clinic visit are reviewed, including payment for PrEP medication and services, lab work and sexual health assessment The competencies for performing a thorough and non-judging sexual history, STI screening, and patient education and practical advice to offer clients regarding adherence are discussed

Module 6

In this module, we review considerations for continuing PrEP beyond the first clinic visit, how to think about the quality of PrEP services, and when discontinuation may be appropriate For patients, topics include medication adherence and risk reduction. For providers, recommendations for management of STIs, screening for and addressing barriers to medication adherence, models of care and case management and clinic retention are reviewed